Congratulations to Voyager Therapeutics on being named one of The Boston Business Journal's 2016 Best Places to Work

Read More

Decibel Therapeutics Launches with $52 million to Discover New Medicines to Protect, Repair and Restore Hearing

Read More

Congrats to partner Mark Levin for being recognized on BBJ's Power 50 list

Read More

Immuno-oncology Company Neon Therapeutics Launches With $55M Series A Financing

Read More

Congrats to our Fierce 15 winners!

Read More

Editas Medicine Selected as a 2015 Technology Pioneer by World Economic Forum

Read More

Third Rock's Discover, Launch, Build strategy featured in Fortune

Read More

Partner Profile: Alexis Borisy

Read More

bluebird bio named a 50 Smartest Company by MIT Technology Review

Read More

Venture partner Steven Paul, M.D. Shares the Story of Founding Voyager Therapeutics

Watch the Video

25 Years in Biotech - Editas CEO, Katrine Bosley, Featured in Xconomy's EXOME
 

Read More

Sign up for weekly portfolio company news alerts here
 

Read More

Editas enters strategic CAR T / TCR-focused collaboration with Juno Therapeutics
 

Read More

SAGE Featured in FORBES article on PPD Trial Results
 

Read More

Andrew Stricos, who has Huntington’s disease, and his wife tell their story at a luncheon hosted by Third Rock

Watch the Video

Transforming Healthcare

35

Portfolio Companies
With More Than $1.3 Billion
Under Management

30

Clinical Studies
Underway Within Our Portfolio

40

Diseases
Being Targeted By
Our Companies

10  

of thousands

Patients Impacted
By Portfolio Company Products
and Clinical Trials